TrialJournal for immunotherapy of cancer2019

Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.

Clint T Allen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.